$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Each year, 42 million people worldwide sustain mild traumatic brain injuries (mTBIs)1. Although once considered benign, new research indicates that mTBIs, particularly repeat mTBIs, can elicit lasting negative consequences, such as physical, cognitive, and sleep disturbances2,3,4. Subsequently, researchers and clinicians are seeking enhanced evaluations and treatment methods to understand and address mTBI.
To date, best practice for mTBI evaluation includes self-reported symptoms and objective measurement of neurocognitive and motor function5. However, some individuals, like competitive collegiate-level athletes, are known to underreport mTBI-related symptoms6, limiting the utility of symptom reports. Objective neurocognitive and motor function measures also have limitations, including poor test-retest reliability, reliance on baseline testing, or insufficient difficulty for high-performing athletes7,8,9. However, dual task paradigms - which simultaneously assess motor and cognitive abilities - can detect subtle, residual impairments and may be particularly useful for evaluating high-performing athletes10,11,12,13,14.
Past research using dual task paradigms have often incorporated cumbersome, expensive laboratory equipment, such as motion capture systems14, to evaluate high-performing athletes. While these systems can accurately measure subtle motor impairments, they are impractical for use in everyday mTBI evaluation due to high equipment cost, limited portability, and long administration times (i.e., ≥ 45 minutes per individual). Further, many past dual task paradigm studies focused solely on lower body or lower extremity skills, such as balance or gait11,12,13,14. Arguably, upper extremity function and hand-eye coordination is also important for high-performing athletes in many sports. Thus, we developed the Dual Task Screen (DTS), which is a brief measure designed to be administered and scored in <10 minutes with portable, low-cost instruments. This original DTS included a lower extremity (LE) and upper extremity (UE) subtask, which evaluated gait speed (using a stopwatch) and hand-eye coordination under single motor and dual task conditions15.
In the first feasibility study, 32 healthy, female adolescent participants completed the original DTS. This study was designed to establish that the DTS could elicit dual task motor costs, as indicated by reduced motor performance during dual task vs. single motor conditions. We also sought to establish that the DTS could be administered and scored in fewer than 10 minutes. We found that all participants had poorer dual task motor performance on at least one subtask. Additionally, we were able to administer the DTS in an average of 5.63 minutes and score the test in 2-3 minutes15.
Although the first feasibility study was successful, a few limitations were revealed. Most notably, gait speed was measured with stopwatches, which are prone to natural human error. Therefore, in the revised DTS we used smart devices with built-in accelerometers (Table of Materials) on each ankle. This addition maintained the use of portable, low-cost instruments while still providing sophisticated measures of gait speed, total number of steps, average step length, average step duration, and step duration variability. Another limitation of the original DTS was the absence of single cognitive conditions, which prevented evaluation of dual task cognitive costs. Dual task cognitive costs are defined as poorer cognitive performance during the dual task vs. single cognitive condition. Subsequently, for both the LE and UE subtasks, we added a single cognitive condition (described in Protocol).
In addition to developing a measure for future clinical use, one of the team’s long-term goals is to evaluate the neural underpinnings of single and dual task performance in healthy athletes and contrast those findings to athletes with sports-induced mTBI. Thus, we have created a neuroimaging-compatible version of the DTS. We seek to determine if the DTS can be successfully modified for use with simultaneous functional near-infrared spectroscopy (fNIRS) measurement, and we are using a mobile fNIRS device specifically designed to accommodate gross-motor movement by reducing the influence of motion artifacts. Further, this device has the greatest amount of head coverage, to our knowledge, for mobile devices that are currently available for research purposes (Table of Materials).
In summary, the study protocol is designed to do the following:
- Describe the administration protocol for the revised Dual Task Screen (DTS), which is a measure we redesigned to address the limitations of the original DTS15 and a measure intended for future clinical use.
- Describe the research protocol for the neuroimaging-compatible Dual Task Screen (DTS), which we have designed to evaluate the neural underpinnings of single and dual task performance.